Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Certified by Founder
Lodge
I2BF Global Ventures
investor
United States
- New York, NY
- 13/12/2022
- Series A
- $21,000,000
I2BF Global Ventures is a New York based venture capital group focused on early stage technology investments with $400 million under management. I2BF’s portfolio includes over 30 companies working in cleantech, biotechnology, materials science, IT and space technology sectors.
- Industry Venture Capital and Private Equity Principals
- Website https://www.i2bf.com/
- LinkedIn https://www.linkedin.com/company/i2bf-global-ventures/
Related People
Ilya GolubovichFounder
United States -
New York, NY
Ilya Golubovich is the founding and managing partner of I2BF Global Ventures, an international venture capital group focused on early stage technology investments with over $500 million under management. I2BF’s portfolio includes over 100 companies working in frontier tech, digital transformation and future of content industries.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)